Soiken Holdings Inc. (2385.T)
JPY 122.0
(-1.61%)
JPY 122.0
(-1.61%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 5.15 Billion JPY | -36.16% |
| 2022 | 8.07 Billion JPY | -13.56% |
| 2021 | 9.34 Billion JPY | 4.53% |
| 2020 | 8.94 Billion JPY | -3.97% |
| 2019 | 9.31 Billion JPY | 23.05% |
| 2018 | 7.56 Billion JPY | 38.74% |
| 2017 | 5.45 Billion JPY | 31.51% |
| 2016 | 4.14 Billion JPY | 29.09% |
| 2015 | 3.21 Billion JPY | 26.06% |
| 2014 | 2.54 Billion JPY | 8.79% |
| 2013 | 2.34 Billion JPY | 19.16% |
| 2012 | 1.96 Billion JPY | 26.98% |
| 2011 | 1.54 Billion JPY | 1.87% |
| 2010 | 1.52 Billion JPY | 5.28% |
| 2009 | 1.44 Billion JPY | -27.09% |
| 2008 | 1.98 Billion JPY | -22.25% |
| 2007 | 2.54 Billion JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 Q4 | 1.31 Billion JPY | 31.6% |
| 2023 FY | 5.15 Billion JPY | -36.16% |
| 2023 Q1 | 1.12 Billion JPY | -24.71% |
| 2023 Q2 | 1.71 Billion JPY | 52.56% |
| 2023 Q3 | 1 Billion JPY | -41.67% |
| 2022 Q1 | 2.21 Billion JPY | -1.66% |
| 2022 FY | 8.07 Billion JPY | -13.56% |
| 2022 Q4 | 1.49 Billion JPY | -36.77% |
| 2022 Q3 | 2.36 Billion JPY | 17.71% |
| 2022 Q2 | 2 Billion JPY | -9.47% |
| 2021 Q3 | 1.94 Billion JPY | -25.06% |
| 2021 Q2 | 2.59 Billion JPY | 1.36% |
| 2021 Q1 | 2.55 Billion JPY | 56.09% |
| 2021 FY | 9.34 Billion JPY | 4.53% |
| 2021 Q4 | 2.25 Billion JPY | 16.02% |
| 2020 Q2 | 2.78 Billion JPY | 1.24% |
| 2020 Q1 | 2.75 Billion JPY | 12.82% |
| 2020 Q4 | 1.63 Billion JPY | -7.28% |
| 2020 Q3 | 1.76 Billion JPY | -36.55% |
| 2020 FY | 8.94 Billion JPY | -3.97% |
| 2019 Q4 | 2.43 Billion JPY | 12.11% |
| 2019 FY | 9.31 Billion JPY | 23.05% |
| 2019 Q1 | 2.31 Billion JPY | 30.23% |
| 2019 Q2 | 2.38 Billion JPY | 2.74% |
| 2019 Q3 | 2.17 Billion JPY | -8.65% |
| 2018 Q4 | 1.77 Billion JPY | 0.5% |
| 2018 Q2 | 1.83 Billion JPY | -16.05% |
| 2018 FY | 7.56 Billion JPY | 38.74% |
| 2018 Q1 | 2.18 Billion JPY | 58.3% |
| 2018 Q3 | 1.77 Billion JPY | -3.42% |
| 2017 Q3 | 1.28 Billion JPY | -5.09% |
| 2017 Q2 | 1.35 Billion JPY | -6.0% |
| 2017 FY | 5.45 Billion JPY | 31.51% |
| 2017 Q1 | 1.43 Billion JPY | 29.72% |
| 2017 Q4 | 1.37 Billion JPY | 7.47% |
| 2016 Q4 | 1.1 Billion JPY | 10.42% |
| 2016 Q1 | 1.05 Billion JPY | 0.98% |
| 2016 FY | 4.14 Billion JPY | 29.09% |
| 2016 Q2 | 982.19 Million JPY | -6.61% |
| 2016 Q3 | 1 Billion JPY | 2.29% |
| 2015 FY | 3.21 Billion JPY | 26.06% |
| 2015 Q4 | 1.04 Billion JPY | 30.01% |
| 2015 Q3 | 801.04 Million JPY | -1.16% |
| 2015 Q2 | 810.47 Million JPY | 44.7% |
| 2015 Q1 | 560.1 Million JPY | -9.38% |
| 2014 Q3 | 597.28 Million JPY | -13.83% |
| 2014 FY | 2.54 Billion JPY | 8.79% |
| 2014 Q4 | 618.05 Million JPY | 3.48% |
| 2014 Q1 | 640.41 Million JPY | 23.22% |
| 2014 Q2 | 693.14 Million JPY | 8.23% |
| 2013 Q3 | 606.84 Million JPY | -7.04% |
| 2013 Q1 | 563.61 Million JPY | 19.7% |
| 2013 Q2 | 652.8 Million JPY | 15.82% |
| 2013 Q4 | 519.72 Million JPY | -14.36% |
| 2013 FY | 2.34 Billion JPY | 19.16% |
| 2012 Q1 | 592.01 Million JPY | 28.37% |
| 2012 Q3 | 416.83 Million JPY | -14.33% |
| 2012 Q2 | 486.58 Million JPY | -17.81% |
| 2012 FY | 1.96 Billion JPY | 26.98% |
| 2012 Q4 | 470.84 Million JPY | 12.96% |
| 2011 FY | 1.54 Billion JPY | 1.87% |
| 2011 Q4 | 461.18 Million JPY | 30.06% |
| 2011 Q3 | 354.58 Million JPY | -8.88% |
| 2011 Q1 | 343.58 Million JPY | 6.1% |
| 2011 Q2 | 389.13 Million JPY | 13.26% |
| 2010 Q2 | 483.56 Million JPY | 36.49% |
| 2010 Q3 | 358.44 Million JPY | -25.87% |
| 2010 FY | 1.52 Billion JPY | 5.28% |
| 2010 Q4 | 323.81 Million JPY | -9.66% |
| 2010 Q1 | 354.29 Million JPY | 1.05% |
| 2009 Q4 | 350.59 Million JPY | 5.53% |
| 2009 FY | 1.44 Billion JPY | -27.09% |
| 2009 Q1 | 332.09 Million JPY | -50.05% |
| 2009 Q2 | 429 Million JPY | 29.18% |
| 2009 Q3 | 332.21 Million JPY | -22.56% |
| 2008 Q4 | 664.79 Million JPY | 107.13% |
| 2008 FY | 1.98 Billion JPY | -22.25% |
| 2008 Q2 | 594.93 Million JPY | 48.86% |
| 2008 Q1 | 399.66 Million JPY | 0.0% |
| 2008 Q3 | 320.96 Million JPY | -46.05% |
| 2007 FY | 2.54 Billion JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | -8.142% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -4467.999% |
| GNI Group Ltd. | 26.01 Billion JPY | 80.168% |
| Linical Co., Ltd. | 12.3 Billion JPY | 58.088% |
| Trans Genic Inc. | 13.08 Billion JPY | 60.573% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -679.762% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | -230.588% |
| AnGes, Inc. | 152.98 Million JPY | -3271.872% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -745.485% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 59.592% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | -531.621% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -3706.755% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | -217.27% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -1104.223% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | -171.326% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -655.858% |
| Kidswell Bio Corporation | 2.43 Billion JPY | -112.174% |
| PeptiDream Inc. | 28.71 Billion JPY | 82.034% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -8083.093% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -4163.188% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -7164425.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -12832.68% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | -14.364% |
| FunPep Company Limited | 530 Thousand JPY | -973193.962% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -7349.037% |
| Stella Pharma Corporation | 269.49 Million JPY | -1814.149% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -1528.209% |
| Cuorips Inc. | 23.1 Million JPY | -22229.054% |
| K Pharma,Inc. | 1 Billion JPY | -415.846% |
| Takara Bio Inc. | 43.5 Billion JPY | 88.143% |
| ReproCELL Incorporated | 2.42 Billion JPY | -112.561% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | -200.728% |
| StemCell Institute Inc. | 2.48 Billion JPY | -107.902% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | -105.174% |
| CellSeed Inc. | 190.13 Million JPY | -2613.064% |